Fluzine

Fluzine may be available in the countries listed below.

Ingredient matches for Fluzine

Flunarizine

Flunarizine is reported as an ingredient of Fluzine in the following countries:

• Taiwan

International Drug Name Search

Rinophar

Rinophar may be available in the countries listed below.

Ingredient matches for Rinophar

Oxymetazoline

Oxymetazoline is reported as an ingredient of Rinophar in the following countries:

• Peru

International Drug Name Search

Vudin

Vudin may be available in the countries listed below.

Ingredient matches for Vudin

Lamivudine

Lamivudine is reported as an ingredient of Vudin in the following countries:

• Bangladesh

International Drug Name Search

Pharmaniaga Nifedipine

Pharmaniaga Nifedipine may be available in the countries listed below.

Ingredient matches for Pharmaniaga Nifedipine

Nifedipine

Nifedipine is reported as an ingredient of Pharmaniaga Nifedipine in the following countries:

• Malaysia

International Drug Name Search

Mycophenolate Mofetil Sandoz

Mycophenolate Mofetil Sandoz may be available in the countries listed below.

Ingredient matches for Mycophenolate Mofetil Sandoz

Mycophenolic Acid

Mycophenolic Acid mofetil (a derivative of Mycophenolic Acid) is reported as an ingredient of Mycophenolate Mofetil Sandoz in the following countries:

• Estonia


• Latvia


• Switzerland

International Drug Name Search

Vitamina C Salf

Vitamina C Salf may be available in the countries listed below.

Ingredient matches for Vitamina C Salf

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Vitamina C Salf in the following countries:

• Italy

International Drug Name Search

Vitaminthe

Vitaminthe may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vitaminthe

Niclosamide

Niclosamide is reported as an ingredient of Vitaminthe in the following countries:

• France

Oxibendazole

Oxibendazole is reported as an ingredient of Vitaminthe in the following countries:

• France

International Drug Name Search

Fosfitone

Fosfitone may be available in the countries listed below.

Ingredient matches for Fosfitone

Suxamethonium Chloride

Suxamethonium Chloride is reported as an ingredient of Fosfitone in the following countries:

• Argentina

International Drug Name Search

Tetra Sanbe

Tetra Sanbe may be available in the countries listed below.

Ingredient matches for Tetra Sanbe

Tetracycline

Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Tetra Sanbe in the following countries:

• Indonesia

International Drug Name Search

Percystan

Percystan may be available in the countries listed below.

Ingredient matches for Percystan

Dipyridamole

Dipyridamole is reported as an ingredient of Percystan in the following countries:

• Japan

International Drug Name Search

Vérapamil Teva

Vérapamil Teva may be available in the countries listed below.

Ingredient matches for Vérapamil Teva

Verapamil

Verapamil hydrochloride (a derivative of Verapamil) is reported as an ingredient of Vérapamil Teva in the following countries:

• France

International Drug Name Search

Clearex Gel

Clearex Gel may be available in the countries listed below.

Ingredient matches for Clearex Gel

Benzoyl Peroxide

Benzoyl Peroxide is reported as an ingredient of Clearex Gel in the following countries:

• Israel

International Drug Name Search

Cétobémidone

Cétobémidone may be available in the countries listed below.

Ingredient matches for Cétobémidone

Ketobemidone

Cétobémidone (DCF) is also known as Ketobemidone (Rec.INN)

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Diprolène

Diprolène may be available in the countries listed below.

Ingredient matches for Diprolène

Betamethasone

Betamethasone 17α,21-dipropionate (a derivative of Betamethasone) is reported as an ingredient of Diprolène in the following countries:

• France

International Drug Name Search

Vidisept

Vidisept may be available in the countries listed below.

Ingredient matches for Vidisept

Povidone

Povidone is reported as an ingredient of Vidisept in the following countries:

• Germany


• Poland

International Drug Name Search

Deprakine

Deprakine may be available in the countries listed below.

Ingredient matches for Deprakine

Valproic Acid

Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Deprakine in the following countries:

• Denmark


• Finland


• Norway

International Drug Name Search

Nimodipino Stada

Nimodipino Stada may be available in the countries listed below.

Ingredient matches for Nimodipino Stada

Nimodipine

Nimodipine is reported as an ingredient of Nimodipino Stada in the following countries:

• Spain

International Drug Name Search

Korec

Korec may be available in the countries listed below.

Ingredient matches for Korec

Quinapril

Quinapril hydrochloride (a derivative of Quinapril) is reported as an ingredient of Korec in the following countries:

• France

International Drug Name Search

Vogalène

Vogalène may be available in the countries listed below.

Ingredient matches for Vogalène

Metopimazine

Metopimazine is reported as an ingredient of Vogalène in the following countries:

• France

International Drug Name Search

Vancocina

Vancocina may be available in the countries listed below.

Ingredient matches for Vancocina

Vancomycin

Vancomycin is reported as an ingredient of Vancocina in the following countries:

• Peru

International Drug Name Search

Kabergolin IVAX

Kabergolin IVAX may be available in the countries listed below.

Ingredient matches for Kabergolin IVAX

Cabergoline

Cabergoline is reported as an ingredient of Kabergolin IVAX in the following countries:

• Sweden

International Drug Name Search

Platino II Filaxis

Platino II Filaxis may be available in the countries listed below.

Ingredient matches for Platino II Filaxis

Cisplatin

Cisplatin is reported as an ingredient of Platino II Filaxis in the following countries:

• Argentina

International Drug Name Search

Medaflox

Medaflox may be available in the countries listed below.

Ingredient matches for Medaflox

Ciprofloxacin

Ciprofloxacin is reported as an ingredient of Medaflox in the following countries:

• Argentina

International Drug Name Search

Clorexil

Clorexil may be available in the countries listed below.

Ingredient matches for Clorexil

Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Clorexil in the following countries:

• Ecuador

International Drug Name Search

Kodein Recip

Kodein Recip may be available in the countries listed below.

Ingredient matches for Kodein Recip

Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Kodein Recip in the following countries:

• Iceland


• Sweden

International Drug Name Search

Quimoral Plus

Quimoral Plus may be available in the countries listed below.

Ingredient matches for Quimoral Plus

Nimesulide

Nimesulide is reported as an ingredient of Quimoral Plus in the following countries:

• Peru

International Drug Name Search

Ophthagreen

Ophthagreen may be available in the countries listed below.

Ingredient matches for Ophthagreen

Indocyanine Green

Indocyanine Green is reported as an ingredient of Ophthagreen in the following countries:

• Japan

International Drug Name Search

Tocilizumab

In the US, Tocilizumab (tocilizumab systemic) is a member of the drug class interleukin inhibitors and is used to treat Juvenile Idiopathic Arthritis and Rheumatoid Arthritis.

US matches:

• Tocilizumab


• Tocilizumab Intravenous


• Tocilizumab Injection

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AC07

CAS registry number (Chemical Abstracts Service)

0375823-41-9

Chemical Formula

C6428-H9976-N1720-O2018-S42

Molecular Weight

144985

Therapeutic Categories

Immunomodulator

Monoclonal antibody

Chemical Name

immunoglobulin G1, anti-(human interleukin 6 receptor) (human-mouse monoclonal MRA heavy chain), disulfide with human-mouse monoclonal MRA kappa-chain, dimer (WHO)

Foreign Names

• Tocilizumabum (Latin)
• Tocilizumab (German)
• Tocilizumab (French)
• Tocilizumab (Spanish)

Generic Names

• Tocilizumab (OS: USAN)
• Atlizumab (IS)
• MRA (IS)
• R-1569 (IS)

Brand Names

• Actemra
  Chugai, Japan; Genentech, United States; Roche, Australia; Roche, Switzerland; Roche, Russian Federation



• RoActemra
  Roche, Germany; Roche, Spain; Roche, United Kingdom; Roche, Ireland; Roche, Sweden; Roche, Slovakia

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Lataz

Lataz may be available in the countries listed below.

Ingredient matches for Lataz

Latanoprost

Latanoprost is reported as an ingredient of Lataz in the following countries:

• Greece

International Drug Name Search

Chlorsig

Chlorsig may be available in the countries listed below.

Ingredient matches for Chlorsig

Chloramphenicol

Chloramphenicol is reported as an ingredient of Chlorsig in the following countries:

• Australia


• New Zealand

International Drug Name Search

Kedrop

Kedrop may be available in the countries listed below.

Ingredient matches for Kedrop

Ketotifen

Ketotifen fumarate (a derivative of Ketotifen) is reported as an ingredient of Kedrop in the following countries:

• Mexico

International Drug Name Search

Czynnik VIII

Czynnik VIII may be available in the countries listed below.

Ingredient matches for Czynnik VIII

Coagulation Factor VIII , Human (rDNA)

Coagulation Factor VIII , Human (rDNA) Octocog Alfa (a derivative of Coagulation Factor VIII , Human (rDNA)) is reported as an ingredient of Czynnik VIII in the following countries:

• Poland

International Drug Name Search

Loperon

Loperon may be available in the countries listed below.

Ingredient matches for Loperon

Loperamide

Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Loperon in the following countries:

• Czech Republic

International Drug Name Search

Pravastax

Pravastax may be available in the countries listed below.

Ingredient matches for Pravastax

Pravastatin

Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Pravastax in the following countries:

• Switzerland

International Drug Name Search

Riboflavin

In some countries, this medicine may only be approved for veterinary use.

In the US, Riboflavin (riboflavin systemic) is a member of the drug class vitamins and is used to treat Dietary Supplementation, Headache, Migraine Prevention and Vitamin/Mineral Supplementation and Deficiency.

US matches:

• Riboflavin


• Riboflavin (Vitamin B2)

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000083-88-5

Chemical Formula

C17-H20-N4-O6

Molecular Weight

376

Therapeutic Category

Vitamin B₂

Chemical Name

Riboflavin

Foreign Names

• Riboflavinum (Latin)
• Riboflavin (German)
• Riboflavine (French)
• Riboflavina (Spanish)

Generic Names

• Riboflavin (OS: BAN)
• Riboflavina (OS: DCIT)
• Riboflavine (OS: DCF)
• E 101 (IS: E Number)
• Lactoflavin (IS: INCI)
• Vitaflavine (IS)
• Vitamin B₂ (IS)
• Riboflavin (PH: BP 2010, JP XIV, Ph. Int. 4, USP 32, Ph. Eur. 6)
• Riboflavina (PH: Ph. Eur. 6)
• Riboflavinum (PH: Ph. Int. 4, Ph. Eur. 6)
• Riboflavin Sodium Phosphate (OS: BANM)
• Riboflavin 5'-phosphate sodium (PH: USP 32)
• Riboflavin Sodium Phosphate (PH: BP 2010, JP XIV, Ph. Eur. 6)
• Riboflavine (phosphate sodique de) (PH: Ph. Eur. 6)
• Riboflavini natrii phosphas (PH: Ph. Eur. 6)
• Riboflavinphosphat-Natrium-Dihydrat (PH: Ph. Eur. 6)
• Butyrate, Riboflavin (PH: JP VIII)

Brand Names

• Alinamin-F (Riboflavin and Fursultiamine)
  Takeda, Indonesia



• B2-ASmedic
  Dyckerhoff, Germany



• Béflavine
  Bayer Santé Familiale, France



• Berivine
  Meuse, Luxembourg; Therabel, Belgium



• Bifuroxin Strong (Riboflavin and Pyridoxine)
  Zonnebode Seiyaku, Japan



• Bisulase
  Toa Eiyo, Japan



• Microvit B2 (veterinary use)
  Adisseo, Australia



• Phosflan
  Fuso Pharmaceutical, Japan



• Riboflavin
  Amico, Bangladesh; Chemist, Bangladesh; Medicon, Bangladesh



• Riboflavina
  Sanitas, Chile



• Riboflavine PCH
  Pharmachemie, Netherlands



• Riboflavine Ratiopharm
  ratiopharm, Netherlands



• Riboflavine
  Rekah, Israel



• Ribon
  Therabel, Belgium; Therabel, Luxembourg



• Ribosina
  Ibn Sina, Bangladesh



• Riboson
  Jayson, Bangladesh



• Ribotab
  Ziska, Bangladesh



• Ribovit
  Gaco, Bangladesh



• Sicovit B2
  Sicomed, Romania



• Vita-B2
  Vitabalans, Finland



• Vitamin B2 Jenapharm
  Mibe Jena, Germany



• Vitamin B2 Streuli
  Streuli Pharma, Switzerland



• Vitamin B2
  Briz, Latvia



• Vitamina B2
  Sunshine, Peru



• Vitaminum B2
  Pliva, Poland; Polfa Kutno, Poland



• Bisulase
  Toa Eiyo, Japan



• Phosflan
  Fuso Pharmaceutical, Japan



• Riboflavin Fosfat
  Sicomed, Romania



• Vitamin B2 Streuli
  Streuli Pharma, Switzerland



• Vitamin B2
  Nichi-Iko PharmaceuticalJMA, Japan



• Bi Love G
  Isei, Japan



• Bi Love
  Isei, Japan



• Fadvitan
  Yoshindo, Japan



• Hibon
  Tanabe Mitsubishi, Japan



• Mitan B2
  Kyorin Rimedio, Japan



• Ribovis
  Tsuruhara Seiyaku, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Bromazepam Temis

Bromazepam Temis may be available in the countries listed below.

Ingredient matches for Bromazepam Temis

Bromazepam

Bromazepam is reported as an ingredient of Bromazepam Temis in the following countries:

• Argentina

International Drug Name Search

Oxymav

Oxymav may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Oxymav

Oxytetracycline

Oxytetracycline hydrochloride (a derivative of Oxytetracycline) is reported as an ingredient of Oxymav in the following countries:

• Australia

International Drug Name Search

Glatiramer Acetate

Scheme

USAN

ATC (Anatomical Therapeutic Chemical Classification)

L03AX13

CAS registry number (Chemical Abstracts Service)

0147245-92-9

Chemical Formula

(C23-H41-N5-O11)x·(C2-H4-O2)x

Therapeutic Category

Immunomodulator

Chemical Name

L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt)

Foreign Name

• Glatiramer acetat (German)

Generic Names

• Glatiramer Acetate (OS: USAN, BAN)
• 147245-92-9 (IS: CAS, old)
• COP 1 (IS: Teva)
• Copolymer 1 (IS)
• Copolymer I (IS: synthetic peptide)
• Glat copolymer (IS)
• Tgal copolymer (IS)

Brand Names

• Copaxone
  Aventis, Luxembourg; Biosintética, Brazil; Dr. Fisher, Netherlands; Elmor, Venezuela; EU-Pharma, Netherlands; Euro, Netherlands; Lemery, Mexico; Med, Turkey; Medco, Peru; Providens, Croatia (Hrvatska); Sanofi-Aventis, Austria; Sanofi-Aventis, Australia; Sanofi-Aventis, Belgium; Sanofi-Aventis, Germany; Sanofi-Aventis, Finland; Sanofi-Aventis, France; Sanofi-Aventis, Georgia; Sanofi-Aventis, Ireland; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Sweden; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal; Sanofi-Aventis S.A.U., Spain; Teva, Argentina; Teva, Bulgaria; Teva, Bulgaria; Teva, Czech Republic; Teva, Germany; Teva, Denmark; Teva, Estonia; Teva, Greece; Teva, Hungary; Teva, Israel; Teva, Iceland; Teva, Italy; Teva, Lithuania; Teva, Luxembourg; Teva, Latvia; Teva, Malta; Teva, Netherlands; Teva, Norway; Teva, Romania; Teva, Serbia; Teva, Slovenia; Teva, Slovakia; Teva Neuroscience, Canada; Teva Neuroscience, United States; Teva Pharma, Switzerland; Teva Pharmaceuticals, United Kingdom; Teva Pharmaceuticals, Poland; Teva Pharmaceuticals, South Africa



• Donecept
  Actavis, Ireland

International Drug Name Search

Glossary

BAN	British Approved Name
CAS	Chemical Abstracts Service
IS	Inofficial Synonym
OS	Official Synonym
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Volon A Tinktur

Volon A Tinktur may be available in the countries listed below.

Ingredient matches for Volon A Tinktur

Salicylic Acid

Salicylic Acid is reported as an ingredient of Volon A Tinktur in the following countries:

• Austria

Triamcinolone

Triamcinolone 16α,17α-acetonide (a derivative of Triamcinolone) is reported as an ingredient of Volon A Tinktur in the following countries:

• Austria

International Drug Name Search

Vita-C

In some countries, this medicine may only be approved for veterinary use.

In the US, Vita-C is a member of the drug class vitamins and is used to treat Dietary Supplementation, Scurvy and Urinary Acidification.

Ingredient matches for Vita-C

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Vita-C in the following countries:

• Finland


• France


• Japan

International Drug Name Search

Xilonibsa Aerosol

Xilonibsa Aerosol may be available in the countries listed below.

Ingredient matches for Xilonibsa Aerosol

Lidocaine

Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Xilonibsa Aerosol in the following countries:

• Spain

International Drug Name Search

Velaglucerase alfa

In the US, Velaglucerase alfa (velaglucerase alfa systemic) is a member of the drug class lysosomal enzymes and is used to treat Gaucher Disease.

US matches:

• Velaglucerase alfa


• Velaglucerase alfa Intravenous

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0884604-91-5

Chemical Formula

C2532-H3850-N672-O711-S16

Therapeutic Category

Enzyme

Foreign Names

• Velaglucerasum alfa (Latin)
• Velaglucerase alfa (German)
• Vélaglucérase alfa (French)
• Velaglucerasa alfa (Spanish)

Generic Names

• Velaglucerase alfa (OS: USAN)
• EC 3.2.1.45 (IS)

Brand Name

• VPRIV
  Shire, United States

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Aquafresh

Aquafresh may be available in the countries listed below.

Ingredient matches for Aquafresh

Sodium Fluoride

Sodium Fluoride is reported as an ingredient of Aquafresh in the following countries:

• Argentina

International Drug Name Search

Viatris

Viatris may be available in the countries listed below.

Ingredient matches for Viatris

Carbasalate Calcium

Carbasalate Calcium is reported as an ingredient of Viatris in the following countries:

• Germany

International Drug Name Search

Propiltiouracilo L.CH.

Propiltiouracilo L.CH. may be available in the countries listed below.

Ingredient matches for Propiltiouracilo L.CH.

Propylthiouracil

Propylthiouracil is reported as an ingredient of Propiltiouracilo L.CH. in the following countries:

• Chile

International Drug Name Search

Velamox CL

Velamox CL may be available in the countries listed below.

Ingredient matches for Velamox CL

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Velamox CL in the following countries:

• Peru

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Velamox CL in the following countries:

• Peru

International Drug Name Search

Diosmine

Diosmine may be available in the countries listed below.

Ingredient matches for Diosmine

Diosmin

Diosmine (DCF) is also known as Diosmin (Rec.INN)

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Y Tex Warrior

Y Tex Warrior may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Y Tex Warrior

Chlorpyrifos

Chlorpyrifos is reported as an ingredient of Y Tex Warrior in the following countries:

• Australia

Dimpylate

Dimpylate is reported as an ingredient of Y Tex Warrior in the following countries:

• Australia

International Drug Name Search

Panthenol Spray

Panthenol Spray may be available in the countries listed below.

Ingredient matches for Panthenol Spray

Dexpanthenol

Dexpanthenol is reported as an ingredient of Panthenol Spray in the following countries:

• Georgia


• Germany


• Lithuania

International Drug Name Search

Acetilcisteina Almus

Acetilcisteina Almus may be available in the countries listed below.

Ingredient matches for Acetilcisteina Almus

Acetylcysteine

Acetylcysteine is reported as an ingredient of Acetilcisteina Almus in the following countries:

• Italy

International Drug Name Search

Madopar Quick

Madopar Quick may be available in the countries listed below.

Ingredient matches for Madopar Quick

Benserazide

Benserazide hydrochloride (a derivative of Benserazide) is reported as an ingredient of Madopar Quick in the following countries:

• Iceland

Levodopa

Levodopa is reported as an ingredient of Madopar Quick in the following countries:

• Iceland

International Drug Name Search

Nonacog Alfa

Nonacog Alfa may be available in the countries listed below.

Ingredient matches for Nonacog Alfa

Coagulation Factor IX, Human, recombinant

Nonacog Alfa (BAN, USAN) is also known as Coagulation Factor IX, Human, recombinant

International Drug Name Search

Glossary

BAN	British Approved Name
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Mefoxitin

Mefoxitin may be available in the countries listed below.

Ingredient matches for Mefoxitin

Cefoxitin

Cefoxitin sodium salt (a derivative of Cefoxitin) is reported as an ingredient of Mefoxitin in the following countries:

• Austria

International Drug Name Search

Vitamin-E-Natur-Kapseln Evi-Mirale

Vitamin-E-Natur-Kapseln Evi-Mirale may be available in the countries listed below.

Ingredient matches for Vitamin-E-Natur-Kapseln Evi-Mirale

Tocopherol, α-

Tocopherol, α- is reported as an ingredient of Vitamin-E-Natur-Kapseln Evi-Mirale in the following countries:

• Germany

International Drug Name Search

Lailixin

Lailixin may be available in the countries listed below.

Ingredient matches for Lailixin

Levofloxacin

Levofloxacin lactate (a derivative of Levofloxacin) is reported as an ingredient of Lailixin in the following countries:

• China

International Drug Name Search

Thiogamma Injekt

Thiogamma Injekt may be available in the countries listed below.

Ingredient matches for Thiogamma Injekt

Thioctic Acid

Thioctic Acid meglumine (a derivative of Thioctic Acid) is reported as an ingredient of Thiogamma Injekt in the following countries:

• Germany

International Drug Name Search

Vancomicina Biocrom

Vancomicina Biocrom may be available in the countries listed below.

Ingredient matches for Vancomicina Biocrom

Vancomycin

Vancomycin is reported as an ingredient of Vancomicina Biocrom in the following countries:

• Argentina

International Drug Name Search

Zasten

Zasten may be available in the countries listed below.

Ingredient matches for Zasten

Ketotifen

Ketotifen is reported as an ingredient of Zasten in the following countries:

• Spain

International Drug Name Search

Ketanserin

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C02KD01

CAS registry number (Chemical Abstracts Service)

0074050-98-9

Chemical Formula

C22-H22-F-N3-O3

Molecular Weight

395

Therapeutic Categories

Vasodilator, peripheric

Antihypertensive agent

Serotonin antagonist

Chemical Name

2,4(1H,3H)-Quinazolinedione, 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-

Foreign Names

• Ketanserinum (Latin)
• Ketanserin (German)
• Kétansérine (French)
• Ketanserina (Spanish)

Generic Names

• Ketanserin (OS: USAN, BAN)
• Ketanserina (OS: DCIT)
• Kétanserine (OS: DCF)
• R 41468 (IS: Janssen)
• Ketanserin Tartrate (OS: BANM)
• KJK 945 (IS)
• R 49945 (IS)

Brand Names

• Sufrexal
  Janssen, Antigua & Barbuda; Janssen, Netherlands Antilles; Janssen, Netherlands Antilles; Janssen, Aruba; Janssen, Aruba; Janssen, Barbados; Janssen, Bermuda; Janssen, Bahamas; Janssen, Costa Rica; Janssen, Dominican Republic; Janssen, Grenada; Janssen, Guatemala; Janssen, Guyana; Janssen, Honduras; Janssen, Jamaica; Janssen, Cayman Islands; Janssen, Saint Lucia; Janssen, Luxembourg; Janssen, Mexico; Janssen, Nicaragua; Janssen, Panama; Janssen, Suriname; Janssen, El Salvador; Janssen, Trinidad & Tobago; Janssen, Saint Vincent & The Grenadines



• Vulketan (veterinary use)
  Janssen Animal Health, Ireland



• Ketanserin
  EU-Pharma, Netherlands



• Ketensin
  Janssen, Netherlands; ProStrakan, Netherlands



• Serepress
  Formenti, Italy



• Sufrexal
  Janssen, Luxembourg; Janssen, Thailand



• Vulketan (veterinary use)
  Biokema, Switzerland; Janssen Animal Health, Belgium; Janssen Pharmaceutica N.V., Luxembourg

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Lenticillin

Lenticillin may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Lenticillin

Benzylpenicillin

Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Lenticillin in the following countries:

• United Kingdom

International Drug Name Search

Diethyltoluamide

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

P03BX01

CAS registry number (Chemical Abstracts Service)

0000134-62-3

Chemical Formula

C12-H17-N-O

Molecular Weight

191

Therapeutic Category

Repellent

Chemical Name

Benzamide, N,N-diethylmethyl-

Foreign Names

• Diethyltoluamidum (Latin)
• Diethyltoluamid (German)
• Diethyltoluamide (French)
• Dietiltoluamida (Spanish)

Generic Names

• Diethyltoluamide (OS: BAN)
• DEET (IS)
• Diethyltoluamide (PH: Ph. Int. 4, USP 32, BP 1980)
• Diethyltoluamidum (PH: Ph. Int. 4)

Brand Names

• Kuritch (veterinary use)
  David Veterinary Laboratories, Australia



• Repel Super Stick Insect Repellent
  Apex, New Zealand

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Risperidon Bluefish

Risperidon Bluefish may be available in the countries listed below.

Ingredient matches for Risperidon Bluefish

Risperidone

Risperidone is reported as an ingredient of Risperidon Bluefish in the following countries:

• Sweden

International Drug Name Search

Closamectine

Closamectine may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Closamectine

Closantel

Closantel sodium salt (a derivative of Closantel) is reported as an ingredient of Closamectine in the following countries:

• France

Ivermectin

Ivermectin is reported as an ingredient of Closamectine in the following countries:

• France

International Drug Name Search

Bromuro de Ipratropio

Bromuro de Ipratropio may be available in the countries listed below.

Ingredient matches for Bromuro de Ipratropio

Ipratropium

Ipratropium Bromide is reported as an ingredient of Bromuro de Ipratropio in the following countries:

• Peru

International Drug Name Search

Aldazide

Aldazide may be available in the countries listed below.

Ingredient matches for Aldazide

Butizide

Butizide is reported as an ingredient of Aldazide in the following countries:

• Indonesia


• South Africa

Spironolactone

Spironolactone is reported as an ingredient of Aldazide in the following countries:

• Indonesia


• South Africa

International Drug Name Search

Dexol 5

Dexol 5 may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Dexol 5

Dexamethasone

Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Dexol 5 in the following countries:

• Australia


• New Zealand

International Drug Name Search

Nervex

Nervex may be available in the countries listed below.

Ingredient matches for Nervex

Mecobalamin

Mecobalamin is reported as an ingredient of Nervex in the following countries:

• Bangladesh

International Drug Name Search

Quinalar

Quinalar may be available in the countries listed below.

Ingredient matches for Quinalar

Quinapril

Quinapril hydrochloride (a derivative of Quinapril) is reported as an ingredient of Quinalar in the following countries:

• Venezuela

International Drug Name Search

Rosoxacin

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01MB01

CAS registry number (Chemical Abstracts Service)

0040034-42-2

Chemical Formula

C17-H14-N2-O3

Molecular Weight

294

Therapeutic Category

Antiinfective, quinolin-derivative

Chemical Name

3-Quinolinecarboxylic acid, 1-ethyl-1,4-dihydro-4-oxo-7-(4-pyridinyl)-

Foreign Names

• Rosoxacinum (Latin)
• Rosoxacin (German)
• Rosoxacine (French)
• Rosoxacino (Spanish)

Generic Names

• Acrosoxacin (OS: BAN)
• Rosoxacin (OS: USAN, BAN)
• Rosoxacine (OS: DCF)
• TO 133 (IS)
• Win 35213 (IS)

Brand Names

• Eradacil
  Sanofi-Aventis, Bahrain; Sanofi-Aventis, Brazil; Sanofi-Aventis, Egypt; Sanofi-Aventis, Kuwait; Sanofi-Aventis, Lebanon; Sanofi-Aventis, Qatar; Sanofi-Aventis, Saudi Arabia; Sanofi-Synthelabo, United Arab Emirates; Sanofi-Synthelabo, Cyprus; Sanofi-Synthelabo, Jordan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Proinsul

Proinsul may be available in the countries listed below.

Ingredient matches for Proinsul

Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Proinsul in the following countries:

• Dominican Republic

International Drug Name Search

Diurace

DiurAce may be available in the countries listed below.

Ingredient matches for DiurAce

Fosinopril

Fosinopril sodium salt (a derivative of Fosinopril) is reported as an ingredient of DiurAce in the following countries:

• Netherlands

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of DiurAce in the following countries:

• Netherlands


• Peru

International Drug Name Search

Burana-C

Burana-C may be available in the countries listed below.

Ingredient matches for Burana-C

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Burana-C in the following countries:

• Finland

Ibuprofen

Ibuprofen is reported as an ingredient of Burana-C in the following countries:

• Finland

International Drug Name Search

Skelaxin

Skelaxin is a brand name of metaxalone, approved by the FDA in the following formulation(s):

SKELAXIN (metaxalone - tablet; oral)

• 
  Manufacturer: KING PHARMS
  
  Approval date: August 30, 2002
  
  Strength(s): 800MG ^[RLD][AB]

Has a generic version of Skelaxin been approved?

A generic version of Skelaxin has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Skelaxin and have been approved by the FDA:

metaxalone tablet; oral

• 
  Manufacturer: SANDOZ
  
  Approval date: March 31, 2010
  
  Strength(s): 800MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Skelaxin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Method for increasing the bioavailability of metaxalone
  Patent 6,407,128
  Issued: June 18, 2002
  Inventor(s): Michael; Scaife & Jaymin; Shah
  Assignee(s): Elan Pharmaceuticals, Inc.
  A method of increasing the bioavailability of metaxalone by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of metaxalone in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.
  
  Patent expiration dates:
  
  
  • December 3, 2021
    
    ✓ 
    Patent use: ENHANCEMENT OF THE BIOAVAILABILITY OF THE DRUG SUBSTANCE
  
  



• 
  Methods of using metaxalone in the treatment of musculoskeletal conditions
  Patent 6,683,102
  Issued: January 27, 2004
  Inventor(s): Michael; Scaife & Jaymin; Shah
  Assignee(s): Elan Pharmaceuticals, Inc.
  A method of increasing the bioavailability of metaxalone by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of metaxalone in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.
  
  Patent expiration dates:
  
  
  • December 3, 2021
    
    ✓ 
    Patent use: ENHANCEMENT OF THE BIOAVAILABILITY OF THE DRUG SUBSTANCE
  
  



• 
  Metaxalone products, method of manufacture, and method of use
  Patent 7,122,566
  Issued: October 17, 2006
  Inventor(s): Du; Jie & Roberts; Richard H.
  Assignee(s): Mutual Pharmaceutical Company, Inc.
  Disclosed herein is a method of using metaxalone. In one embodiment, the method comprises obtaining metaxalone from a container providing information that metaxalone affects the activity of a cytochrome p450 isozyme. In another embodiment, the method comprises informing a user that metaxalone affects the activity of a cytochrome p450 isozyme. Also included are articles of manufacture comprising a container containing a dosage form of metaxalone, wherein the container is associated with published material informing that metaxalone affects activity of a cytochrome p450 isozyme. Also disclosed are a method of treatment and a method of manufacturing a metaxalone product.
  
  Patent expiration dates:
  
  
  • February 6, 2026
    
    ✓ 
    Patent use: TREATMENT OF MUSCULOSKELETAL CONDITIONS
  
  



• 
  Methods of modifying the bioavailability of metaxalone
  Patent 7,714,006
  Issued: May 11, 2010
  Inventor(s): Scaife; Michael C. & Davis; Charles C.
  Assignee(s): King Pharmaceuticals Research & Development, Inc.
  A method of increasing the bioavailability, and decreasing the effect of age on the bioavailability, of metaxalone, by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of metaxalone in a suitable container and associated with printed labeling which describes the increased bioavailability, and decreased effect of age on bioavailability, of the medication in the container, when taken with food.
  
  Patent expiration dates:
  
  
  • December 3, 2021
    
    ✓ 
    Patent use: USE OF METAXALONE FOR TREATMENT OF MUSCULSKELETAL CONDITIONS
  
  

See also...

• Skelaxin Consumer Information (Drugs.com)
• Skelaxin Consumer Information (Wolters Kluwer)
• Skelaxin Consumer Information (Cerner Multum)
• Skelaxin Advanced Consumer Information (Micromedex)
• Skelaxin AHFS DI Monographs (ASHP)
• Metaxalone Consumer Information (Wolters Kluwer)
• Metaxalone Consumer Information (Cerner Multum)
• Metaxalone Advanced Consumer Information (Micromedex)
• Metaxalone AHFS DI Monographs (ASHP)

Plenaer

Plenaer may be available in the countries listed below.

Ingredient matches for Plenaer

Flunisolide

Flunisolide is reported as an ingredient of Plenaer in the following countries:

• Italy

Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Plenaer in the following countries:

• Italy

International Drug Name Search

Lumex

Lumex may be available in the countries listed below.

Ingredient matches for Lumex

Lomefloxacin

Lomefloxacin hydrochloride (a derivative of Lomefloxacin) is reported as an ingredient of Lumex in the following countries:

• Bangladesh

International Drug Name Search

Dopamine Aguettant

Dopamine Aguettant may be available in the countries listed below.

Ingredient matches for Dopamine Aguettant

Dopamine

Dopamine is reported as an ingredient of Dopamine Aguettant in the following countries:

• Tunisia

Dopamine hydrochloride (a derivative of Dopamine) is reported as an ingredient of Dopamine Aguettant in the following countries:

• France

International Drug Name Search

Vifex

Vifex may be available in the countries listed below.

Ingredient matches for Vifex

Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Vifex in the following countries:

• Myanmar

International Drug Name Search

Hioscina Fada

Hioscina Fada may be available in the countries listed below.

Ingredient matches for Hioscina Fada

Scopolamine

Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Hioscina Fada in the following countries:

• Argentina

International Drug Name Search

Velkalov

Velkalov may be available in the countries listed below.

Ingredient matches for Velkalov

Lovastatin

Lovastatin is reported as an ingredient of Velkalov in the following countries:

• Greece

International Drug Name Search

Vericordin

Vericordin may be available in the countries listed below.

Ingredient matches for Vericordin

Atenolol

Atenolol is reported as an ingredient of Vericordin in the following countries:

• Argentina

International Drug Name Search

Terbinafina Ciclum

Terbinafina Ciclum may be available in the countries listed below.

Ingredient matches for Terbinafina Ciclum

Terbinafine

Terbinafine is reported as an ingredient of Terbinafina Ciclum in the following countries:

• Portugal

International Drug Name Search

Amoxicilina UQP

Amoxicilina UQP may be available in the countries listed below.

Ingredient matches for Amoxicilina UQP

Amoxicillin

Amoxicillin is reported as an ingredient of Amoxicilina UQP in the following countries:

• Peru

International Drug Name Search

Thymazen

Thymazen may be available in the countries listed below.

Ingredient matches for Thymazen

Tymazoline

Tymazoline hydrochloride (a derivative of Tymazoline) is reported as an ingredient of Thymazen in the following countries:

• Poland

International Drug Name Search

Famonerton

Famonerton may be available in the countries listed below.

Ingredient matches for Famonerton

Famotidine

Famotidine is reported as an ingredient of Famonerton in the following countries:

• Germany

International Drug Name Search

Ventolin CR

Ventolin CR may be available in the countries listed below.

Ingredient matches for Ventolin CR

Salbutamol

Salbutamol is reported as an ingredient of Ventolin CR in the following countries:

• Vietnam

International Drug Name Search

Fentanyl DBL

Fentanyl DBL may be available in the countries listed below.

Ingredient matches for Fentanyl DBL

Fentanyl

Fentanyl is reported as an ingredient of Fentanyl DBL in the following countries:

• Taiwan

Fentanyl citrate (a derivative of Fentanyl) is reported as an ingredient of Fentanyl DBL in the following countries:

• Bangladesh

International Drug Name Search

Gonasi HP

Gonasi HP may be available in the countries listed below.

Ingredient matches for Gonasi HP

Chorionic Gonadotrophin

Chorionic Gonadotrophin is reported as an ingredient of Gonasi HP in the following countries:

• Italy


• Malta

International Drug Name Search

Nutropin AQ

See also: Generic Nutropin

Nutropin AQ is a brand name of somatropin, approved by the FDA in the following formulation(s):

NUTROPIN AQ (somatropin recombinant - injectable; injection)

• 
  Manufacturer: GENENTECH
  
  Approval date: December 29, 1995
  
  Strength(s): 10MG/2ML (5MG/ML) ^[RLD]


• 
  Manufacturer: GENENTECH
  
  Approval date: January 3, 2008
  
  Strength(s): 20MG/2ML (10MG/ML) ^[RLD], 5MG/2ML (2.5MG/ML) ^[RLD]


• 
  Manufacturer: GENENTECH
  
  Approval date: April 22, 2002
  
  Strength(s): 10MG/2ML (5MG/ML) ^[RLD]

Has a generic version of Nutropin AQ been approved?

No. There is currently no therapeutically equivalent version of Nutropin AQ available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Nutropin AQ. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Human growth hormone aqueous formulation
  Patent 5,763,394
  Issued: June 9, 1998
  Inventor(s): O'Connor; Barbara H. & Oeswein; James Q.
  Assignee(s): Genentech, Inc.
  A stable pharmaceutically acceptable aqueous formulation containing human growth hormone, a buffer, a non-ionic surfactant, and, optionally, a neutral salt, mannitol, or, a preservative, is disclosed. Also disclosed are associated means and methods for preparing, storing, and using such formulations.
  
  Patent expiration dates:
  
  
  • June 9, 2015
    
    ✓ 
    Drug product
  
  

See also...

• Nutropin AQ Consumer Information (Wolters Kluwer)
• Nutropin AQ NuSpin Consumer Information (Wolters Kluwer)
• Nutropin AQ Pen Consumer Information (Wolters Kluwer)
• Nutropin AQ Vials Consumer Information (Wolters Kluwer)
• Nutropin AQ Consumer Information (Cerner Multum)
• Nutropin AQ NuSpin 10 Advanced Consumer Information (Micromedex)
• Nutropin AQ NuSpin 5 Advanced Consumer Information (Micromedex)
• Nutropin AQ Pen Advanced Consumer Information (Micromedex)
• Nutropin Aq Subcutaneous, Injection Advanced Consumer Information (Micromedex)
• Somatropin (rDNA origin - Nonrefrigerated) Consumer Information (Wolters Kluwer)
• Somatropin (rDNA origin - Refrigerated) Consumer Information (Wolters Kluwer)
• Somatropin (rDNA origin - Refrigerated) Cartridge Consumer Information (Wolters Kluwer)
• Somatropin (rDNA origin - Refrigerated) Vial Consumer Information (Wolters Kluwer)
• Somatropin (rDNA origin - Refrigerated) Vials Consumer Information (Wolters Kluwer)
• Somatropin Consumer Information (Cerner Multum)
• Somatropin, e-coli derived Subcutaneous, Injection Advanced Consumer Information (Micromedex)
• Somatropin, mammalian derived Subcutaneous, Injection Advanced Consumer Information (Micromedex)

Atines

Atines may be available in the countries listed below.

Ingredient matches for Atines

Eperisone

Eperisone hydrochloride (a derivative of Eperisone) is reported as an ingredient of Atines in the following countries:

• Japan

International Drug Name Search

Vitamina C Angelini

Vitamina C Angelini may be available in the countries listed below.

Ingredient matches for Vitamina C Angelini

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Vitamina C Angelini in the following countries:

• Italy

International Drug Name Search

Vinorelbin Sandoz

Vinorelbin Sandoz may be available in the countries listed below.

Ingredient matches for Vinorelbin Sandoz

Vinorelbine

Vinorelbine tartrate (a derivative of Vinorelbine) is reported as an ingredient of Vinorelbin Sandoz in the following countries:

• Austria


• Slovakia

International Drug Name Search

darbepoetin alfa Injection

dar-be-POE-e-tin AL-fa

Injection route(Solution)

Erythropoiesis-stimulating agents (ESAs) increase the risks for death, myocardial infarction, stroke, and other serious cardiovascular events. In patients with chronic kidney disease (CKD), patients are at a greater risk for death, serious adverse cardiovascular reactions, and stroke when administered ESAs to target Hb levels of 11 g/dL or higher in clinical studies. No trial has identified a Hb target level, ESA dose, or dosing strategy that does not increase these risks. Therefore, in CKD patients, use at the lowest sufficient dose is recommended. In cancer patients with certain tumor types (ie, breast, non-small cell lung, head and neck, lymphoid, cervical), ESAs shortened overall survival and/or increased the risk of tumor progression or recurrence in some clinical studies. In patients with cancer, use the lowest ESA dose needed to avoid RBC transfusions and serious cardiovascular and thromboembolic reactions. Use ESAs only for treatment of anemia due to concomitant myelosuppressive chemotherapy, and discontinue following the completion of a chemotherapy course. Prescribers and hospitals must enroll in and comply with the ESA APPRISE Oncology Program (www.esa-apprise.com or 1-866-284-8089) to prescribe and/or dispense darbepoetin alfa to patients with cancer. Patients receiving myelosuppressive therapy should not be treated with ESAs when the anticipated outcome is cure .

Commonly used brand name(s)

In the U.S.

• Aranesp

Available Dosage Forms:

• Solution

Therapeutic Class: Hematopoietic

Pharmacologic Class: Erythropoietic

Uses For darbepoetin alfa

Darbepoetin alfa injection causes the bone marrow to produce red blood cells. If the body does not produce enough red blood cells, severe anemia can occur. This often occurs in people with chronic kidney failure whose kidneys are not working properly. Darbepoetin may be used for patients on kidney dialysis or for those not on dialysis. Anemia can also occur in people who are receiving chemotherapy to treat cancer. Darbepoetin alfa is used to treat severe anemia in these patients.

darbepoetin alfa is available only with your doctor's prescription.

Before Using darbepoetin alfa

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For darbepoetin alfa, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to darbepoetin alfa or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of darbepoetin alfa injection in children with chronic kidney failure who are 1 year of age and older. Safety and efficacy have not been established in children with chronic kidney failure who are younger than 1 year of age.

Appropriate studies have not been performed on the relationship of age to the effects of darbepoetin alfa injection in children with cancer. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of darbepoetin alfa injection in the elderly.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking darbepoetin alfa, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using darbepoetin alfa with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Thalidomide

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of darbepoetin alfa. Make sure you tell your doctor if you have any other medical problems, especially:

• Aluminum poisoning, severe or


• Bleeding, severe or


• Bone marrow fibrosis (osteofibrosis cystica) or


• Folic acid deficiency or


• Infections, inflammation, or cancer or


• Iron deficiency or


• Vitamin B12 deficiency—May cause a delay in response to treatment.

• Blood clots (history of) or other problems with the blood or


• Congestive heart failure or


• Heart attack, history of or


• Heart bypass surgery or


• Heart or blood vessel disease or


• Stroke, history of or


• Thrombosis, at risk for—The chance of side effects may be increased.

• Bone marrow problems (e.g., hemolytic anemia, sickle cell anemia, porphyria, thalassemia)—Use of darbepoetin alfa injection has not been established in patients with these conditions.

• Hypertension (high blood pressure), uncontrolled or


• Pure red cell aplasia (rare bone marrow disease)—Should not be used in patients with these conditions.

• Seizures, history of—May make this condition worse.

Proper Use of darbepoetin alfa

For cancer patients: It is very important that you understand and become familiar with the Aranesp® Medication Guide. You may also be asked to sign the ESA APPRISE Oncology Program Patient and Healthcare Professional (HCP) acknowledgement form. Direct any questions to your doctor or pharmacist before starting darbepoetin alfa therapy.

darbepoetin alfa comes with a patient instructions insert. Read and follow these instructions carefully. Ask your doctor if you have any questions.

Darbepoetin alfa is usually given by a doctor. However, medicines given by injection are sometimes used at home. If you will be using darbepoetin alfa at home, your doctor will teach you how the injections are to be given. Be sure you understand exactly how the medicine is to be injected.

darbepoetin alfa is available in 3 forms. You may use a vial, a prefilled syringe with an UltraSafe® Needle Guard, or a prefilled SureClick™ autoinjector.

If you need a full dose of darbepoetin alfa, use the prefilled SureClick™ autoinjector unless your doctor tells you otherwise.

darbepoetin alfa may be given as a shot under your skin or into a vein. If your doctor tells you to inject it a certain way, follow your doctor's instructions.

If you are giving darbepoetin alfa at home:

• Use a new needle and syringe each time you inject your medicine.


• Do not use more medicine or use it more often than your doctor tells you to.


• You will be shown the body areas where this shot can be given.


• Throw away used needles and syringes in a hard, closed container that the needles cannot poke through (puncture-resistant). Keep this container away from children and pets.

Do not shake the container of medicine before you use it, and do not use darbepoetin alfa if it has been frozen.

You might not use all of the medicine in each vial (glass container) or prefilled syringe. Use each vial or syringe only one time. Do not save an open vial or syringe. If the medicine in the vial or syringe has changed color, or if you see particles in it, do not use it.

Carefully follow your doctor's instructions about any special diet. You may need to eat foods that contain iron, folic acid, or vitamin B12 such as eggs, certain cereals, meats, and vegetables, or you may take an iron, folic acid, or vitamin B12 supplement while you are using darbepoetin alfa.

Dosing

The dose of darbepoetin alfa will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of darbepoetin alfa. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• For injection dosage form:
  
  • For anemia from chronic kidney failure:
    
    • Adults—Dose is based on body weight and must be determined by your doctor. The starting dose is 0.45 to 0.75 microgram (mcg) per kilogram (kg) of body weight injected into a vein or under the skin once a week or once every 2 weeks. Your doctor may adjust the dose as needed.
    
    
    • Children—Use and dose must be determined by your doctor.
    
    
  
  
  • For anemia from cancer chemotherapy:
    
    • Adults—Dose is based on body weight and must be determined by your doctor. The starting dose is 2.25 micrograms (mcg) per kilogram (kg) of body weight once a week or 500 mcg once every 3 weeks injected under the skin. Your doctor may adjust the dose as needed.
    
    
    • Children—Use and dose must be determined by your doctor.
    
    
  
  

Missed Dose

Call your doctor or pharmacist for instructions.

Storage

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Ask your healthcare professional how you should dispose of any medicine you do not use.

Store in the refrigerator. Do not freeze.

Protect the medicine from bright light. Keep your medicine in the original package until you are ready to use it.

Precautions While Using darbepoetin alfa

People with severe anemia usually feel very tired and sick. When darbepoetin alfa begins to work, usually in about 6 weeks, most people start to feel better. Some people are able to be more active. But darbepoetin alfa only corrects anemia. It has no effect on kidney disease, cancer, or any other medical problem that needs regular medical attention. Even if you are feeling much better, it is very important that you do not miss any appointments with your doctor or any dialysis treatments.

It is very important that your doctor check your blood regularly while you are using darbepoetin alfa. You may also need to monitor your blood pressure at home. If you notice any changes to your normal blood pressure, call your doctor right away.

Darbepoetin alfa may cause a serious type of allergic reaction called anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Stop using darbepoetin alfa and check with your doctor right away if you have a rash; itching; swelling of the face, tongue, and throat; trouble with breathing; or chest pain after you receive the medicine.

darbepoetin alfa may increase your risk of having blood clots. This is more likely in patients who use high doses of darbepoetin alfa, or who use darbepoetin alfa before major surgery. If you have chest pain; shortness of breath; or pain, redness, or swelling in your arms or legs while using darbepoetin alfa, call your doctor right away. If you are getting kidney dialysis treatments, tell your doctor right away if you notice blood clots at your injection site. Your doctor may give you a blood thinner before surgery to help prevent blood clots.

darbepoetin alfa may also increase your risk of having serious heart and blood vessel problems such as a heart attack, congestive heart failure, or stroke. Check with your doctor right away if you start having dizziness, fainting spells, severe tiredness, chest pain, trouble with breathing, sudden or severe headache, or problems with vision, speech, or walking.

When used in patients with certain types of cancer (e.g., breast, cervix, lymphoid, lung, head, or neck cancer), darbepoetin alfa has shortened survival time and worsened the cancer in some patients. If you are concerned about this, talk with your doctor.

Darbepoetin alfa sometimes causes convulsions (seizures), especially during the first few months of treatment. During this time, it is best to avoid driving, operating heavy machinery, or other activities that could cause a serious injury if a seizure occurs while you are performing them.

One form of darbepoetin alfa injection has an ingredient that comes from donated human blood. Some human blood products have transmitted certain viruses to people who have received them. The risk of getting a virus from medicines made from human blood has been greatly reduced in recent years. This is the result of required testing of human donors for certain viruses, and testing during the making of these medicines. Although the risk is low, talk with your doctor if you have concerns.

The needle cover of the prefilled syringe contains dry natural rubber (a derivative of latex), which may cause allergic reactions in people who are sensitive to latex. Tell your doctor if you have a latex allergy before you start using darbepoetin alfa.

Many people with kidney problems need to be on a special diet. Also, people with high blood pressure (which may be caused by kidney disease or by darbepoetin alfa treatment) may need to be on a special diet or to take medicine to keep their blood pressure under control. After their anemia has been corrected, some people feel so much better that they want to eat more than before. To keep your kidney disease or your high blood pressure from getting worse, it is very important that you follow your special diet and take your medicines regularly, even if you are feeling better.

In addition to darbepoetin alfa, your body needs iron and vitamins to make red blood cells. Your doctor may direct you to take iron or vitamin supplements. Be sure to follow your doctor's orders carefully. Darbepoetin alfa will not work well if you do not have enough iron or vitamins in your body.

darbepoetin alfa Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

More common

• Abdominal or stomach pain


• accumulation of pus


• arm, back, or jaw pain


• blurred vision


• breathing problems (irregular, noisy, or trouble when resting)


• chest pain, discomfort, tightness, or heaviness


• chills


• confusion


• cough producing mucus


• decrease in the amount of urine


• diarrhea


• dilated neck veins


• dizziness, fainting, or lightheadedness


• dry mouth


• fast, slow, or irregular heartbeat


• fatigue or tiredness (extreme or unusual)


• fever


• headache


• nausea


• pain, tenderness, swelling, or warmth over injection site


• pounding in the ears


• rapid breathing


• rapid or pounding pulse


• shortness of breath


• skin discoloration at the injection site


• sunken eyes


• sweating


• swelling of the ankles, face, fingers, feet, hands, or lower legs


• thirst


• trouble with breathing


• unconsciousness


• vomiting


• weight gain


• wheezing


• wrinkled skin

Less common

• Anxiety


• convulsions


• difficulty with speaking (slow speech or unable to speak)


• double vision


• trouble with thinking


• trouble with walking


• unable to move the arms, legs, or face muscles (including numbness and tingling)

Rare

• Fever and sore throat


• hives


• itching


• pale skin


• skin rash


• unusual tiredness or weakness

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• Constipation


• general feeling of discomfort or illness


• lack or loss of strength


• loss of appetite


• muscle aches, pains, or stiffness


• pain in the joints


• runny nose


• shivering


• sneezing


• trouble with sleeping

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: darbepoetin alfa Injection side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More darbepoetin alfa Injection resources

• Darbepoetin alfa Injection Side Effects (in more detail)
• Darbepoetin alfa Injection Use in Pregnancy & Breastfeeding
• Darbepoetin alfa Injection Drug Interactions
• Darbepoetin alfa Injection Support Group
• 1 Review for Darbepoetin alfa Injection - Add your own review/rating

Compare darbepoetin alfa Injection with other medications

• Anemia Associated with Chronic Renal Failure
• Anemia, Chemotherapy Induced